Anixa Biosciences to Participate in the 2022 Virtual Growth Conference Hosted by M-Vest, a Division of Maxim Group LLC
SAN JOSE, Calif., March 17, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the Company will present at the 2022 Virtual Growth Conference, hosted by M-Vest, a division of Maxim Group LLC, on March 28th – 30th from 9:00 am – 5:00 pm EDT.
During this virtual conference, Anixa's Chief Operating Officer and Chief Financial Officer, Mike Catelani, will provide an overview of Anixa's business and an update on the Company's programs. To attend the conference and view the presentation, sign up to become an M-Vest member here.
About Anixa Biosciences, Inc.
Anixa is a publicly-traded
biotechnology company developing a number of programs addressing cancer
and infectious disease. Anixa's therapeutics portfolio includes a cancer
immunotherapy program which uses a novel type of CAR-T, known as
chimeric endocrine receptor T-cell (CER-T) technology, and a COVID-19
therapeutics program focused on inhibiting certain viral protein
function. The company's vaccine portfolio includes a vaccine to prevent
breast cancer – specifically triple negative breast cancer (TNBC), the
most lethal form of the disease – and a vaccine to prevent ovarian
cancer. These vaccine technologies focus on immunizing against specific
proteins that have been found to be expressed in certain forms of
cancer. Anixa continually examines emerging technologies in
complementary fields for further development and commercialization.
Additional information is available at www.anixa.com.
Contacts
Company Contact:
Mike Catelani
Chief Operating Officer and Chief Financial Officer
mcatelani@anixa.com
408-708-9808
Media:
Slavena Salve Nissan, M.D.
LifeSci Communications
snissan@lifescicomms.com
718-483-4440
Investors:
Eric Ribner
LifeSci Advisors, LLC
eric@lifesciadvisors.com
646-751-4363
View original content to download multimedia:https://www.prnewswire.com/news-releases/anixa-biosciences-to-participate-in-the-2022-virtual-growth-conference-hosted-by-m-vest-a-division-of-maxim-group-llc-301504842.html
SOURCE Anixa Biosciences, Inc.
